How will we define 'low-risk'? EVEREST-HN is an NIHR-funded research programme that is aiming to develop a risk stratification tool. Find out more here: www.royalmarsden.nhs.uk/everest-hn
royalmarsden.nhs.uk
EVEREST-HN | The Royal Marsden
Everest is a research programme aimed at improving the suspected head and neck cancer pathway, speeding up diagnosis, improving the patient experience and optimising the use of healthcare resources.